Literature DB >> 15616832

Magnetic resonance imaging visualization of targeted cells by the internalization of supramolecular adducts formed between avidin and biotinylated Gd3+ chelates.

Simonetta Geninatti Crich1, Alessandro Barge, Elisa Battistini, Claudia Cabella, Sara Coluccia, Dario Longo, Valentina Mainero, Guido Tarone, Silvio Aime.   

Abstract

The high binding affinity between avidin and biotin has been exploited to develop a procedure for magnetic resonance imaging (MRI) visualization of target cells. SHIN3 and PANC1 tumor cell lines have been used as target cells because they possess on their membranes galactosyl receptors able to bind avidin molecules. Avidin-Gd chelate adducts have been built by using two Gd complexes containing one (Gd-I) and two (Gd-II) biotin residues, respectively. The relaxivities of such supramolecular adducts are significantly higher than those shown by free Gd-I and Gd-II. There is evidence of the occurrence of multilayered adducts in which the bis-biotinylated Gd(3+) complex acts as a bridge between adjacent avidin molecules. MRI differentiation of labeled versus unlabeled cells has been attained when approximately 6 x 10(8) Gd units were internalized in each cell. Furthermore, there is a marked decrease in the measured intracellular T(1) relaxivity as the number of internalized Gd complexes increases, probably owing to too short relaxation times of endosomic water protons with respect to their diffusion lifetime.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15616832     DOI: 10.1007/s00775-004-0616-2

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  25 in total

Review 1.  Molecular imaging.

Authors:  R Weissleder; U Mahmood
Journal:  Radiology       Date:  2001-05       Impact factor: 11.105

2.  Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging.

Authors:  D A Sipkins; D A Cheresh; M R Kazemi; L M Nevin; M D Bednarski; K C Li
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

3.  L-Glutamic acid and L-lysine as useful building blocks for the preparation of bifunctional DTPA-like ligands.

Authors:  P L Anelli; F Fedeli; O Gazzotti; L Lattuada; G Lux; F Rebasti
Journal:  Bioconjug Chem       Date:  1999 Jan-Feb       Impact factor: 4.774

Review 4.  Lectins in cancer cells.

Authors:  R Lotan; A Raz
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

Review 5.  Pretargeted radioimmunotherapy of cancer: progress step by step.

Authors:  Otto C Boerman; Frank G van Schaijk; Wim J G Oyen; Frans H M Corstens
Journal:  J Nucl Med       Date:  2003-03       Impact factor: 10.057

6.  Biotin reagents for antibody pretargeting. 2. Synthesis and in vitro evaluation of biotin dimers and trimers for cross-linking of streptavidin.

Authors:  D S Wilbur; P M Pathare; D K Hamlin; S A Weerawarna
Journal:  Bioconjug Chem       Date:  1997 Nov-Dec       Impact factor: 4.774

7.  Magnetic resonance molecular imaging of the HER-2/neu receptor.

Authors:  Dmitri Artemov; Noriko Mori; Rajani Ravi; Zaver M Bhujwalla
Journal:  Cancer Res       Date:  2003-06-01       Impact factor: 12.701

8.  The use of bifunctional biotinyl compounds to determine the arrangement of subunits in avidin.

Authors:  N M Green; L Konieczny; E J Toms; R C Valentine
Journal:  Biochem J       Date:  1971-12       Impact factor: 3.857

9.  MRI detection of early endothelial activation in brain inflammation.

Authors:  Nicola R Sibson; Andrew M Blamire; Martine Bernades-Silva; Sophie Laurent; Sébastien Boutry; Robert N Muller; Peter Styles; Daniel C Anthony
Journal:  Magn Reson Med       Date:  2004-02       Impact factor: 4.668

10.  Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.

Authors:  Patrick M Winter; Shelton D Caruthers; Andrea Kassner; Thomas D Harris; Lori K Chinen; John S Allen; Elizabeth K Lacy; Huiying Zhang; J David Robertson; Samuel A Wickline; Gregory M Lanza
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

View more
  12 in total

Review 1.  Imaging in cell-based therapy for neurodegenerative diseases.

Authors:  Deniz Kirik; Nathalie Breysse; Tomas Björklund; Laurent Besret; Philippe Hantraye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

Review 2.  [Molecular imaging: future uses in arthritides].

Authors:  M H Brem; P M Schlechtweg; J Mackenzie; C S Winalski; P Lang
Journal:  Radiologe       Date:  2006-05       Impact factor: 0.635

3.  Controlled aggregation of ferritin to modulate MRI relaxivity.

Authors:  Kevin M Bennett; Erik M Shapiro; Christopher H Sotak; Alan P Koretsky
Journal:  Biophys J       Date:  2008-03-07       Impact factor: 4.033

4.  Labeling fibroblasts with biotin-BSA-GdDTPA-FAM for tracking of tumor-associated stroma by fluorescence and MR imaging.

Authors:  D Granot; L A Kunz-Schughart; M Neeman
Journal:  Magn Reson Med       Date:  2005-10       Impact factor: 4.668

5.  An iron-based T1 contrast agent made of iron-phosphate complexes: in vitro and in vivo studies.

Authors:  Elisenda Rodríguez; Rui V Simoes; Anna Roig; Elies Molins; Nataliya Nedelko; Anna Slawska-Waniewska; Silvio Aime; Carles Arús; Miquel E Cabañas; Coral Sanfeliu; Sebastián Cerdán; Maria Luisa García-Martín
Journal:  MAGMA       Date:  2007-02-01       Impact factor: 2.310

6.  Cationized ferritin as a magnetic resonance imaging probe to detect microstructural changes in a rat model of non-alcoholic steatohepatitis.

Authors:  Scott C Beeman; Lawrence J Mandarino; Joseph F Georges; Kevin M Bennett
Journal:  Magn Reson Med       Date:  2013-12       Impact factor: 4.668

Review 7.  Molecular Sensing with Host Systems for Hyperpolarized 129Xe.

Authors:  Jabadurai Jayapaul; Leif Schröder
Journal:  Molecules       Date:  2020-10-11       Impact factor: 4.411

8.  Harnessing competing endocytic pathways for overcoming the tumor-blood barrier: magnetic resonance imaging and near-infrared imaging of bifunctional contrast media.

Authors:  Helena Sheikhet Migalovich; Vyacheslav Kalchenko; Nava Nevo; Gila Meir; Fortune Kohen; Michal Neeman
Journal:  Cancer Res       Date:  2009-06-09       Impact factor: 12.701

9.  MRI of the basement membrane using charged nanoparticles as contrast agents.

Authors:  Kevin M Bennett; Hua Zhou; James P Sumner; Stephen J Dodd; Nadia Bouraoud; Kent Doi; Robert A Star; Alan P Koretsky
Journal:  Magn Reson Med       Date:  2008-09       Impact factor: 4.668

10.  HER2 targeted molecular MR imaging using a de novo designed protein contrast agent.

Authors:  Jingjuan Qiao; Shunyi Li; Lixia Wei; Jie Jiang; Robert Long; Hui Mao; Ling Wei; Liya Wang; Hua Yang; Hans E Grossniklaus; Zhi-Ren Liu; Jenny J Yang
Journal:  PLoS One       Date:  2011-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.